Drug intelligence / Profile preview

Refresh Digital

Development stage: Unknown
Lead developer: Allergan
Modality: Small Molecules
Administration: Ophthalmic

Overview

Refresh Digital is an over-the-counter (OTC) lubricant eye drop product developed by Allergan (now part of AbbVie) specifically formulated to address dryness and irritation associated with digital device use and screen time. The formulation contains a combination of three active ingredients: carboxymethylcellulose sodium, glycerin, and polysorbate 80. It features proprietary HydroCell technology, which is a sodium chloride-free, glycerin-based solution designed to hydrate and support all three layers of the tear film. The product is available in both multi-dose preserved bottles (using the PURITE preservative) and single-use preservative-free (PF) vials.

Brand names: Refresh DigitalRefresh Digital PF

Beyond the preview

Go deeper on Refresh Digital.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Refresh Digital.

Explore the full profile